Related Experiment Videos
Asplenism and systemic lupus erythematosus
1Clinique de Rhumatologie (Centre Viggo Petersen), Hôpital Lariboisière, Paris, France.
Clinical Rheumatology
|March 1, 1995
Summary
Congenital asplenism (lack of a spleen) in a patient with systemic lupus erythematosus (SLE) highlights a rare but serious condition. Patients with no spleen and SLE face a high risk of severe pneumococcal infections, underscoring the need for vaccination.
Area of Science:
- Immunology
- Rheumatology
- Genetics
Background:
- Systemic lupus erythematosus (SLE) is an autoimmune disease where the immune system attacks healthy tissues.
- Functional hyposplenism, characterized by impaired spleen function, is known in SLE due to immune complex deposition.
- Complete congenital asplenism (congenital absence of the spleen) is a rare condition with limited reported cases in SLE patients.
Observation:
- A 60-year-old woman with congenital asplenism presented with active systemic lupus erythematosus.
- This case prompts a review of clinical characteristics and disease course in patients with both conditions.
- The interplay between the absence of a spleen and the onset or severity of SLE is explored.
Findings:
- Congenital asplenism may be associated with the initiation and progression of systemic lupus erythematosus.
- Patients with congenital asplenism and SLE exhibit unique clinical presentations and disease trajectories.
- The spleen's role in immune regulation is critical, and its absence can exacerbate autoimmune conditions.
Implications:
- Individuals with congenital asplenism and SLE are at a significantly elevated risk for overwhelming postsplenectomy infection (OPSI), particularly fatal pneumococcemia.
- Prophylactic pneumococcal vaccination is strongly recommended for these high-risk patients.
- Further research is needed to clarify the long-term efficacy and optimal strategies for pneumococcal vaccination in asplenic SLE patients.